Matej Mikulic
Research expert covering health, pharma & medtech
Global pharmaceutical outsourcing - statistics & facts
罢丑别听global pharmaceutical market reached about $1.7 trillion in 2024 and is projected to surpass about $2.4 trillion by 2029, supported by an expanding drug pipeline and sustained R&D investment. This growth has coincided with a fundamental shift in how pharma companies organize their operations. The outsourcing share of services expenditure rose from about 34% in 2014 to about 49% by 2023, with in-house spending falling below the majority threshold for the first time. This is not simply a cost-reduction response; it reflects an industry increasingly recognizing that therapeutic complexity and speed-to-market requirements exceed what internal structures can efficiently deliver alone.
